A 1999 clinical study that Merck & Co Inc (MRK.N) said was done to test side effects of its now-withdrawn painkiller Vioxx was done primarily to support a marketing campaign before its launch, according to researchers.
The real aim of the study, called ADVANTAGE, was to promote prescription of the new medicine when it became available -- a so-called "seeding" project -- U.S. researchers said on Tuesday.
"Documentary evidence shows that ADVANTAGE is an example of marketing framed as science," they wrote in the journal Annals of Internal Medicine.
Kevin Hill, a psychiatrist at McLean Hospital in Belmont, Mass., and colleagues said the findings showed how studies masquerading as clinical science could be used to bolster marketing plans.
One of the strictest abortion bans in the country will be on the ballot this November...
Martha Lillard, who contracted polio at age five and spent most of her life dependent on...
One in four Israelis now engages in harmful substance use as the psychological fallout from Israel’s...
New York City’s famed Solomon R Guggenheim Museum was among a number of Manhattan buildings that...
